Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals

Submitted by amarin on Thu, 02/09/2023 - 13:01
Letter Underscores the Change That is Being Led by Amarin’s New Board Highlights Sarissa’s Track Record of Value Destruction in the Healthcare Space Sarissa Continues to Mislead Shareholders by Distorting Facts and Promoting Misinformation DUBLIN, Ireland and BRIDGEWATER., N.J., Feb.

Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals

Submitted by amarin on Thu, 02/09/2023 - 13:00
Letter Underscores the Change That is Being Led by Amarin’s New Board Highlights Sarissa’s Track Record of Value Destruction in the Healthcare Space Sarissa Continues to Mislead Shareholders by Distorting Facts and Promoting Misinformation DUBLIN, Ireland and BRIDGEWATER., N.J., Feb.

Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts

Submitted by amarin on Mon, 02/06/2023 - 13:01
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE Proxy Card DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a

Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts

Submitted by amarin on Mon, 02/06/2023 - 13:00
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE Proxy Card DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a